Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two Amgen EPO Patent Infringement Claims Upheld By Federal Appeals Court

This article was originally published in The Pink Sheet Daily

Executive Summary

In a mixed decision, the appeals court also reversed a lower court's decision that rival drug makers had infringed a different patent.

You may also be interested in...



Amgen Knocks Roche In Early Round Of EPO Court Fight

Federal judge rules that Roche’s EPO product Mircera infringes a key Amgen patent, although trial is still set for Sept. 4.

Amgen Knocks Roche In Early Round Of EPO Court Fight

Federal judge rules that Roche’s EPO product Mircera infringes a key Amgen patent, although trial is still set for Sept. 4.

Amgen Bundling Discounts Will Continue As J&J Case Heads To Trial

Court denies injunction sought by J&J to stop Amgen discounts based on amount of anemia products purchased.

Related Content

Topics

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel